#KotakMahindraBank is set to release its #Q4 earnings today. According to a CNBC-TV18 poll, co is likely to report NII of ₹6,670.2 cr, a 9.3% year-over-year increase from ₹6,102.6 cr
ANUP ENGINEERING:
Q4 CONS NET PROFIT 430M RUPEES VS 195M (YOY)
Q4 EBITDA RUPEES 373M VS 302M (YOY) || Q4 EBITDA MARGIN 23.8% VS 20.93% (YOY)
Q4 CONS NET PROFIT 430M RUPEES VS 195M (YOY)
Q4 EBITDA RUPEES 373M VS 302M (YOY) || Q4 EBITDA MARGIN 23.8% VS 20.93% (YOY)
SUN PHARMA: CO TO ACQUIRE VALSTAR S.A., INCLUDING ITS UNIT KEMIPHARM S.A., FOR UP TO USD 31M
VA TECH WABAG: CO LAUNCHES BLUE SEED A PIONEERING INITIATIVE TO EMPOWER PROMISING START-UPS IN WATER SECTOR
All #restrictions on #OnionExport removed with effect from today. Decision took into account estimated Rabi 2024 production & good prospect of Kharif crop: Government Officials
ZYDUS LIFE: CO'S UNIT IN US ACQUIRES WORLDWIDE PROPRIETARY RIGHTS TO ZOKINVY AT NET BASE PRICE OF USD 45M FROM US-BASED EIGER BIOPHARMACEUTICALS
ZOKINVY (LONAFARNIB) FOR TREATMENT OF HUTCHINSON-GILFORD PROGERIA SYNDROME FROM EIGER BIOPHARMACEUTICALS
ZOKINVY (LONAFARNIB) FOR TREATMENT OF HUTCHINSON-GILFORD PROGERIA SYNDROME FROM EIGER BIOPHARMACEUTICALS
#IDBIBank reports #Q4Results
▶️Net profit up 43.7% at Rs 1,628.5 cr vs Rs 1,133.4 cr (YoY)
▶️NII up 12.4% at Rs 3,687.9 cr vs Rs 3,279.6 cr (YoY)
▶️Gross NPA at Rs 8,916.8 cr vs Rs 8,589.4 cr (QoQ)
▶️Net NPA at Rs 643.8 cr vs Rs 593.3 cr (QoQ)
▶️Gross NPA at 4.53% vs 4.69% (QoQ)
▶️Net NPA unchanged at 0.34% (QoQ)
▶️Net profit up 43.7% at Rs 1,628.5 cr vs Rs 1,133.4 cr (YoY)
▶️NII up 12.4% at Rs 3,687.9 cr vs Rs 3,279.6 cr (YoY)
▶️Gross NPA at Rs 8,916.8 cr vs Rs 8,589.4 cr (QoQ)
▶️Net NPA at Rs 643.8 cr vs Rs 593.3 cr (QoQ)
▶️Gross NPA at 4.53% vs 4.69% (QoQ)
▶️Net NPA unchanged at 0.34% (QoQ)
IDBI Bank Ltd:-
IDBI Bank Limited - Financial Results for Q4 & FY 2024 IDBI Bank reports 55% rise in profits on YoY basis
➡️ Net Profit surges to all time high at ₹5,634 crore for the year with YoY
growth of 55% and ₹1,628 crore for Q4 FY 24 with QoQ growth of 12%
➡️ The Board proposed dividend of 15%, subject to approval of the
members at the ensuing Annual General Meeting
➡️ Gross NPA down to 4.53%, YoY reduction by 185 bps
➡️ Net NPA down to 0.34%, YoY reduction by 58 bps
➡️ Provision Coverage Ratio (PCR) at 99.09%
➡️ CRAR at 22.26%
➡️ CASA Ratio at 50.43%
IDBI Bank Limited - Financial Results for Q4 & FY 2024 IDBI Bank reports 55% rise in profits on YoY basis
➡️ Net Profit surges to all time high at ₹5,634 crore for the year with YoY
growth of 55% and ₹1,628 crore for Q4 FY 24 with QoQ growth of 12%
➡️ The Board proposed dividend of 15%, subject to approval of the
members at the ensuing Annual General Meeting
➡️ Gross NPA down to 4.53%, YoY reduction by 185 bps
➡️ Net NPA down to 0.34%, YoY reduction by 58 bps
➡️ Provision Coverage Ratio (PCR) at 99.09%
➡️ CRAR at 22.26%
➡️ CASA Ratio at 50.43%